Evaluation Conformity Rejimen Peptic Ulcer Drug Therapy In Inpatient Care Facility At West Nusa Tenggara Regional Public Hospital

Recta Olivia Umboro, Fitri Apriliany, Vera Fitriya Ersalena

Abstract


Peptic ulcers are lesions in the stomach or duodenum caused by an imbalance between aggressive and mucosal protective factors. External factors such as smoking, coffee consumption, and helycobacter pylori infection are triggers for peptic ulcers. In 2017, there is an increase in the prevalence of gastritis (dyspepsia, peptic ulcer) in West Nusa Tenggara. The aim of this research to determine the description and appropriateness of drug therapy in patients with peptic ulcers. The observational method was used in this research with a descriptive cross-sectional study design. Data were collected retrospectively through tracing treatment  on the medical records of peptic ulcer patients at the in-patient facility of the West Nusa Tenggara Regional Public Hospital for the period January 2018 - January 2020. Based on inclusion and exclusion criteria, the number of prescriptions is 114 from 18 patients. The patient characteristic based on age was obtained between 55 – 64 years with a percentage of 50% with 55,56% suffered by men. The largest percentage of therapy was between PPI + Antacids + Sucraflat (38,89%). The percentage of the PPI group were omeprazole (88.89%) and lansoprazole (22.22%). In H2RA group, ranitidine (16.67%). Sucraflat (83.33%), ondansetron (33.33%) and antacids (55.56%). The percentage of the suitability of drug therapy is 88%. The percentage of dosage therapy appropriate is 100%.

 


Keywords


Peptic Ulcer; Drug Therapy Choice; Dose Appropriate

Full Text:

References


DiPiro BGWJT, DiPiro TLSC V. Pharmacotherapy Handbook Ninth Edition, Barbara G. Wells, PharmD, FASHP, FCCP, 2015 by McGraw-Hill Education. McGraw-Hill Education; 2015.

Rani AA, Simadibrata M, Syam AF. Buku ajar gastroenterologi. Ilmu Penyakit Dalam FKUI. 1st ed. Jakarta Pusat: Interna Publishing. 2011. 55–65 p.

AW Sudoyo; B Setiyohadi; I Alwi; M Simadibrata; S Setiati. Buku Ajar Ilmu Penyakit Dalam Edisi IV jilid III. Buku Ajar Ilmu Penyakit Dalam Edisi IV jilid III, 0. 148. Ilmu penyakit dalam. AW Sudoyo, B Setiyohadi, I Alwi, M Simadibrata, S Setiati. Edisi 5, 161-162, 2006. 2006.

Dinas Kesehatan. Profil Kesehatan Provinsi Nusa Tenggara Barat Tahun 2017. In: Provinsi Nusa Tenggara Barat Tahun 2017. 2017. p. 1–85.

Kurata JH, Haile BM. Epidemiology of peptic ulcer disease. Clin Gastroenterol. 1984;13(2):289–307.

Avunduk C. Manual of gastroenterology: diagnosis and therapy. Lippincott Williams & Wilkins; 2008.

Di Saverio S, Bassi M, Smerieri N, Masetti M, Ferrara F, Fabbri C, et al. Diagnosis and treatment of perforated or bleeding peptic ulcers: 2013 WSES position paper. World J Emerg Surg. 2014;9(1):1–15.

Siregar C.J.P dan Kumolosari E. Farmasi Klinik: Teori an Penerapannya. Buku Kedokteran EGC: Jakarta. 2004.

Suadicani P, Hein HO, Gyntelberg F. Genetic and life-style determinants of peptic ulcer: A study of 3387 men aged 54 to 74 years: The Copenhagen Male Study. Scand J Gastroenterol. 1999;34(1):12–7.

Angkow J, Robot F, Onibala F. Faktor-Faktor Yang Berhubungan Dengan Kejadian Gastritis Di Wilayah Kerja Puskesmas Bahu Kota Manado. J Keperawatan UNSRAT. 2014;2(2):111136.

Anwar IF, Khomsan IA. Makan Tepat Badan Sehat. Hikmah; 2009.

Ilham MI. Hubungan Pola Konsumsi Kopi Terhadap Kejadian Gastristis Pada Mahasiswa Muhammadiyah Parepare. J Ilm Mns Dan Kesehat. 2019;2(3):433–46.

Stupak DP, Abdelsayed GG, Soloway GN. Motility disorders of the upper gastrointestinal tract in the intensive care unit: pathophysiology and contemporary management. J Clin Gastroenterol. 2012;46(6):449–56.

Maity P, Biswas K, Roy S, Banerjee RK, Bandyopadhyay U. Smoking and the pathogenesis of gastroduodenal ulcer–recent mechanistic update. Mol Cell Biochem. 2003;253(1):329–38.

Maulidiyah U., HUBUNGAN ANTARA STRES DAN KEBIASAAN MAKAN DENGAN TERJADINYA KEKAMBUHAN PENYAKIT GASTRITIS: Studi Pada Penderita Gastritis di Balai Pengobatan Dan Rumah Bersalin Mawaddah Kecamatan Ngoro Kabupaten Mojokerto. 2006;

Selviana BY. Effect of Coffee and Stress with the Incidence of Gastritis. J Major. 2015;4(2).

Pranarka K. Penerapan Geriatrik Kedokteran Menuju Usia Lanjut yang Sehat. Universa Med. 2006;25(4):187–97.

Suzuki RB, Cola RF, Cola LTB, Ferrari CG, Ellinger F, Therezo AL, et al. Different risk factors influence peptic ulcer disease development in a Brazilian population. World J Gastroenterol. 2012;18(38):5404–11.

Waranugraha Y, Pratomo B, Studi P, Dokter P, Kedokteran F, Brawijaya U, et al. Hubungan Pola Penggunaan OAINS dengan Gejala Klinis Gastropati pada Pasien Reumatik Relationship of NSAID Utilization Pattern With Gastropathy Symptoms in Rheumatic Patient. J Kedokt Brawijaya. 2010;26(2):107–12.

Becker JC, Domschke W, Pohle T. Current approaches to prevent NSAID‐induced gastropathy–COX selectivity and beyond. Br J Clin Pharmacol. 2004;58(6):587–600.

Radjamin ISP, Nusi IA, Kalanjati VP. Profil Penderita Gastro Esophageal Reflux Disease (GERD) dan Non-Erosive Reflux Disease (Nerd) di RSUD Dr. Soetomo Surabaya. Maj Biomorfologi. 2019;29(1):13–8.

Oner R, Karincaoglu M. Correlation of dyspeptic symptoms and endoscopic findings in diabetic patient. Med Sci Discov. 2018;90(532):130–6.

Ari F. Profil kerusakan mukosa gastroduodenal pada pengguna aspirin dosis rendah jangka panjang di rscm serta faktor-faktor yang mempengaruhi. 2016;39–41.

Leontiadis GI, Molloy-Bland M, Moayyedi P, Howden CW. Effect of comorbidity on mortality in patients with peptic ulcer bleeding: systematic review and meta-analysis. Am J Gastroenterol. 2013;108(3):331–45.

Sudoyo AW, Setiyohadi B, Alwi I, Simadibrata M, Setiati S. Buku Ajar Ilmu Penyakit Dalam Jilid II edisi V. Vol. 310, Jakarta: Interna Publishing. 2009. 1973–1982 p.

Santika NY, Desnita R, Yuswar MA. Evaluasi Penggunaan Obat Tukak Peptik pada Pasien Tukak Peptik di Instalasi Rawat Inap RSUD Sultan Syarif Mohamad Alkadrie Pontianak. Maj Farmseutik. 2019;15(1):1–15.

Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG, Posey LM. Pharmacotherapy: A Pathophysiologic Approach, ed. McGraw-Hill Medical, New York; 2014.

Debas HT. Gastrointestinal surgery: pathophysiology and management. Springer Science & Business Media; 2004.

Nabilla R, Iriawan J, R.J. Nuriatin. Gambaran Karakteristik Dan Prognosis Pasien Perdarahan Saluran Cerna Bagian Atas Berdasarkan Glasgow Blachtford Score Di Rs Dustira Tahun 2016. Bagian Endosk Fak Kedokt Unjani. 2016.

Rizqah, Nur’aini, Fajrin Noviyanto. EVALUASI PENGGUNAAN OBAT TUKAK PEPTIK PADA PASIEN TUKAK PEPTIK (Peptic Ulcer Disease) DI RUMAH SAKIT BHAYANGKARA BRIMOB TAHUN 2015. Farmagazine. 2016;III(2).

Tjay TH, Rahardja K. Obat-obat penting: khasiat, penggunaan dan efek-efek sampingnya. Elex Media Komputindo; 2007.

Nikose S, Arora M. Gastrointestinal Adverse Effects due to Use of Non-Steroidal Anti- Inflammatory Drugs (NSAIDs) in Non-Traumatic Painful Musculoskeletal Disorders. J Gastrointest Dig Syst. 2015;

Cryer B, Mahaffey KW. Gastrointestinal ulcers, role of aspirin, and clinical outcomes: pathobiology, diagnosis, and treatment. J Multidiscip Healthc. 2014;7:137.

Song YR, Kim HJ, Kim WK, Kim SG, Kim SE. Proton-pump inhibitors for prevention of upper gastrointestinal bleeding in patients undergoing dialysis. World J Gastroenterol. 2015;21(16):4919–24.

Dewi NLMI. EVALUASI PENGGUNAAN OBAT TUKAK PEPTIK PADA PASIEN DEWASA DI INSTALASI RAWAT INAP RUMAH SAKIT BETHESDA YOGYAKARTA TAHUN 2016-2018. USDACID. 2019;

Drini M. Peptic ulcer disease and non-steroidal anti ‑ inflammatory drugs. Aust Prescr. 2017;40(3):91–3.

Hastuti DW. Pola penggunaan obat tukak peptik (peptic ulcer disease) pada pasien geriatrik di instalasi rawat inap RSUD Dr. Moewardi Tahun 2006-2010. 2011;

Hsu PI. New look at antiplatelet agent-related peptic ulcer: An update of prevention and treatment. J Gastroenterol Hepatol. 2012;27(4):654–61.

Fauziah D.W. GAMBARAN PENGGUNAAN SUKRALFAT PADA PASIEN GASTRITIS RAWAT INAP PENYAKIT DALAM DI RS. HASANUDDIN DAMRAH BENGKULU. J Penelit dan Kaji Ilm Kesehat Politek Medica Farma Husada Mataram. 2019;5(1):46–52.




DOI: https://doi.org/10.30591/pjif.v11i1.2481

Refbacks

  • There are currently no refbacks.


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.

 

===============================================================

Parapemikir : Jurnal Ilmiah Farmasi

Program Studi D-3 Farmasi
Politeknik Harapan Bersama Tegal
Jl. Mataram No.09 Pesurungan Lor Kota Tegal

Telp. +62283 - 352000

Email :[email protected]

 

Copyright: Parapemikir : Jurnal Ilmiah Farmasi p-ISSN:2089-5313 e-ISSN:2549-5062

 

===============================================================

 

Parapemikir Indexed By : 

 

 

Flag Counter

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

View My Stats